Bio-Rad Laboratories (BIO) Long-Term Deferred Tax (2009 - 2019)

Bio-Rad Laboratories (BIO) has 11 years of Long-Term Deferred Tax data on file, last reported at $138.0 million in Q4 2019.

• On a quarterly basis, Long-Term Deferred Tax rose 80.87% year-over-year to $138.0 million in Q4 2019; TTM through Dec 2019 was $138.0 million, a 80.87% increase from a year earlier, with the FY2019 full-year figure at $138.0 million, up 80.87% from the prior year.
• Long-Term Deferred Tax for Q4 2019 stood at $138.0 million, up from $76.3 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for BIO reached as high as $138.0 million in Q4 2019 and fell as low as $76.3 million in Q4 2018.
• Historically, Long-Term Deferred Tax has averaged $102.2 million across 5 years, with a median of $99.5 million in 2015.
• Across the five-year window, Long-Term Deferred Tax slumped 32.77% in 2017 and soared 80.87% in 2019, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $99.5 million in 2015, then gained by 18.39% to $117.8 million in 2016, then slumped by 32.77% to $79.2 million in 2017, then declined by 3.66% to $76.3 million in 2018, then soared by 80.87% to $138.0 million in 2019.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $138.0 million in Q4 2019, $76.3 million in Q4 2018, and $79.2 million in Q4 2017.